Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1

Recall Insight

This FDA Drug action (record #D-0157-2021) was formally reported on December 23, 2020, with the manufacturer initiating the action on November 17, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. Taro Pharmaceuticals U.S.A., Inc. is listed as the recalling firm, operating out of Hawthorne, NY. Federal records indicate 11,088 1 oz tubes units are affected, a scale large enough to require multi-state distribution tracking.

The documented reason for this recall is: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%. Distribution data in the federal record shows the product reached: Distributed Nationwide in the USA and Canada. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 4 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 6 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.